Medical Devices & Supplies: Leases (ASC 842)

The following table summarizes the cash paid for amounts included in the measurement of operating lease liabilities and right-of-use assets obtained in exchange for operating lease liabilities for fiscal years 2026, 2025, and 2024:

Fiscal Year
(in millions)	2026	2025	2024
Cash paid for amounts included in the measurement of operating lease liabilities	270	233	232
Right-of-use assets obtained in exchange for operating lease liabilities	290	281	220

The following table summarizes the maturities of the Company's operating leases at April 24, 2026:

(in millions) Fiscal Year	Operating Leases
2027	223
2028	196
2029	160
2030	133
2031	111
Thereafter	552
Total expected lease payments	1,376
Less: Imputed interest	( 188 )
Total lease liability	1,188

The Company makes certain products available to customers under lease arrangements, including arrangements whereby equipment is placed with customers who then purchase consumable products to accompany the use of the equipment. Income arising from arrangements where the Company is the lessor is recognized within net sales in the consolidated statements of income and the Company's net investments in sales-type leases are included in other current assets and other assets in the consolidated balance sheets. Lessor income for fiscal years

Medtronic plc

Notes to Consolidated Financial Statements (Continued)

2026, 2025, and 2024 and the related assets and lease maturities at April 24, 2026 and April 25, 2025 were not material to the consolidated financial statements.

17. Accumulated Other Comprehensive Loss